In 2009, Kleinschek et al. identified human CD161+ CD4 T cells as a resting Th17 pool that can be activated by IL-23 and mediate destructive tissue inflammation using blood and fresh colon specimens from patients with Crohn’s disease [37]. This evidence concerns the gene KLRB1 and Crohn disease.